These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34262675)

  • 1. Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy.
    Park KS; Svennerholm K; Crescitelli R; Lässer C; Gribonika I; Lötvall J
    J Extracell Vesicles; 2021 Jul; 10(9):e12120. PubMed ID: 34262675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2.
    Park KS; Svennerholm K; Crescitelli R; Lässer C; Gribonika I; Andersson M; Boström J; Alalam H; Harandi AM; Farewell A; Lötvall J
    J Nanobiotechnology; 2023 May; 21(1):156. PubMed ID: 37208676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome-minimized outer membrane vesicles from
    Zanella I; König E; Tomasi M; Gagliardi A; Frattini L; Fantappiè L; Irene C; Zerbini F; Caproni E; Isaac SJ; Grigolato M; Corbellari R; Valensin S; Ferlenghi I; Giusti F; Bini L; Ashhab Y; Grandi A; Grandi G
    J Extracell Vesicles; 2021 Feb; 10(4):e12066. PubMed ID: 33643549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass-produced gram-negative bacterial outer membrane vesicles activate cancer antigen-specific stem-like CD8
    Won S; Lee C; Bae S; Lee J; Choi D; Kim MG; Song S; Lee J; Kim E; Shin H; Basukala A; Lee TR; Lee DS; Gho YS
    J Extracell Vesicles; 2023 Aug; 12(8):e12357. PubMed ID: 37563797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
    Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust Immune Response Induced by
    Barbosa MMF; Kanno AI; Barazzone GC; Rodriguez D; Pancakova V; Trentini M; Faquim-Mauro EL; Freitas AP; Khouri MI; Lobo-Silva J; Goncalves VM; Schenkman RPF; Tanizaki MM; Boraschi D; Malley R; Farias LP; Leite LCC
    Int J Nanomedicine; 2021; 16():7153-7168. PubMed ID: 34712047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy.
    Qing S; Lyu C; Zhu L; Pan C; Wang S; Li F; Wang J; Yue H; Gao X; Jia R; Wei W; Ma G
    Adv Mater; 2020 Nov; 32(47):e2002085. PubMed ID: 33015871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.
    Tsukamoto H; Kubota K; Shichiku A; Maekawa M; Mano N; Yagita H; Ohta S; Tomioka Y
    Immunology; 2019 Oct; 158(2):136-149. PubMed ID: 31515801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10.
    Park KS; Svennerholm K; Shelke GV; Bandeira E; Lässer C; Jang SC; Chandode R; Gribonika I; Lötvall J
    Stem Cell Res Ther; 2019 Aug; 10(1):231. PubMed ID: 31370884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses.
    Kim OY; Hong BS; Park KS; Yoon YJ; Choi SJ; Lee WH; Roh TY; Lötvall J; Kim YK; Gho YS
    J Immunol; 2013 Apr; 190(8):4092-102. PubMed ID: 23514742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial Outer Membrane Vesicle-Mediated Cytosolic Delivery of Flagellin Triggers Host NLRC4 Canonical Inflammasome Signaling.
    Yang J; Hwang I; Lee E; Shin SJ; Lee EJ; Rhee JH; Yu JW
    Front Immunol; 2020; 11():581165. PubMed ID: 33312172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant effect of bacterial outer membrane vesicles with penta-acylated lipopolysaccharide on antigen-specific T cell priming.
    Lee DH; Kim SH; Kang W; Choi YS; Lee SH; Lee SR; You S; Lee HK; Chang KT; Shin EC
    Vaccine; 2011 Oct; 29(46):8293-301. PubMed ID: 21893142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Myd88 using peptide-loaded mesenchymal stem cell membrane-derived synthetic vesicles to treat systemic inflammation.
    Park KS; Bergqvist M; Lässer C; Lötvall J
    J Nanobiotechnology; 2022 Oct; 20(1):451. PubMed ID: 36243859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45.
    Pritsch M; Ben-Khaled N; Chaloupka M; Kobold S; Berens-Riha N; Peter A; Liegl G; Schubert S; Hoelscher M; Löscher T; Wieser A
    J Immunol Res; 2016; 2016():3576028. PubMed ID: 27239480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour.
    Song S; Zhang K; You H; Wang J; Wang Z; Yan C; Liu F
    Clin Exp Immunol; 2010 Oct; 162(1):75-83. PubMed ID: 20735440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic Escherichia coli (APEC).
    Hu R; Li J; Zhao Y; Lin H; Liang L; Wang M; Liu H; Min Y; Gao Y; Yang M
    Microb Cell Fact; 2020 Jun; 19(1):119. PubMed ID: 32493405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.